Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 663-671 |
| Number of pages | 18 |
| Journal | Nature Genetics |
| Volume | 53 |
| Issue number | 5 |
| Early online date | 22 Apr 2021 |
| DOIs | |
| Publication status | Published - May 2021 |
Funding
We thank G. Davey Smith for insightful comments. This research was conducted by using the UK Biobank resource under application no. 31063. A.G. was supported by the Academy of Finland Fellowship (no. 323116). This work was supported by the Medical Research Council (Unit Programme number MC_UU_12015/2). M.G.N. is a fellow of the Jacobs Foundation and is supported by ZonMw grant nos. 849200011 and 531003014 from the Netherlands Organization for Health Research and Development and a VENI grant awarded by the Dutch Research Council (VI.Veni.191G.030). A. Abdellaoui is supported by the Foundation Volksbond Rotterdam and ZonMw grant no. 849200011 from the Netherlands Organization for Health Research and Development. The FinnGen project is funded by 2 grants from Business Finland (nos. HUS 4685/31/2016 and UH 4386/31/2016) and 11 industry partners (AbbVie, AstraZeneca UK, Biogen MA, Celgene Corporation, Celgene International II S\u00E0rl, Genentech, Merck Sharp & Dohme Corp, Pfizer, GlaxoSmithKline, Sanofi, Maze Therapeutics, Janssen Biotech). We thank the following biobanks for collecting the FinnGen project samples: Auria Biobank (https://www.auria.fi/biopankki/); THL Biobank (https://thl.fi/en/web/thl-biobank); Helsinki Biobank (https://www.helsinginbiopankki.fi/fi/etusivu); Biobank Borealis of Northern Finland (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/ Biobank-Borealis-briefly-in-English.aspx); Finnish Clinical Biobank Tampere (https:// www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere); Biobank of Eastern Finland (https://ita-suomenbiopankki.fi/en/); Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/Biopankki); Finnish Red Cross Blood Service Biobank (https://www.veripalvelu.fi/verenluovutus/biopankkitoiminta); and Terveystalo Biobank (https://www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/ Biopankki/). All Finnish Biobanks are members of the BBMRI.fi infrastructure (http:// www.bbmri.fi/). We thank the research participants and employees of 23andMe who contributed to this study.
| Funders | Funder number |
|---|---|
| Biogen MA | |
| Foundation Volksbond Rotterdam | |
| Maze Therapeutics | |
| Netherlands Organization for Health Research and Development | |
| Pfizer | |
| Genentech | |
| GlaxoSmithKline | |
| Sanofi | |
| Janssen Biotech | |
| Celgene | |
| AbbVie | |
| Merck Sharp and Dohme | |
| Medical Research Council | MC_UU_12015/2 |
| Medical Research Council | |
| ZonMw | 531003014, 849200011 |
| ZonMw | |
| Academy of Finland | 323116 |
| Academy of Finland | |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | VI.Veni.191G.030 |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
| Jacobs Foundation | |
| Business Finland | HUS 4685/31/2016, UH 4386/31/2016 |
| Business Finland |
Fingerprint
Dive into the research topics of 'Genetic analyses identify widespread sex-differential participation bias'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver